Order Article Reprints

Sahajpal NS, Mondal AK, Singh H, Vashisht A, Ananth S, Saul D, Hastie AR, Hilton B, DuPont BR, Savage NM, et al. Clinical Utility of Optical Genome Mapping and 523-Gene Next Generation Sequencing Panel for Comprehensive Evaluation of Myeloid Cancers. Cancers. 2023; 15(12):3214. https://doi.org/10.3390/cancers15123214

Sahajpal, Nikhil Shri, Ashis K. Mondal, Harmanpreet Singh, Ashutosh Vashisht, Sudha Ananth, Daniel Saul, Alex R. Hastie, Benjamin Hilton, Barbara R. DuPont, Natasha M. Savage, and et al. 2023. "Clinical Utility of Optical Genome Mapping and 523-Gene Next Generation Sequencing Panel for Comprehensive Evaluation of Myeloid Cancers" Cancers 15, no. 12: 3214. https://doi.org/10.3390/cancers15123214

Sahajpal, N. S., Mondal, A. K., Singh, H., Vashisht, A., Ananth, S., Saul, D., Hastie, A. R., Hilton, B., DuPont, B. R., Savage, N. M., Kota, V., Chaubey, A., Cortes, J. E., & Kolhe, R. (2023). Clinical Utility of Optical Genome Mapping and 523-Gene Next Generation Sequencing Panel for Comprehensive Evaluation of Myeloid Cancers. Cancers, 15(12), 3214. https://doi.org/10.3390/cancers15123214